[1]
E. Office, “The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H. pylori eradication therapy”, Turkish Journal of Gastroenterology, vol. 23, no. 6, pp. 805–806, Jan. 2012.